http://orcid.org/0000-0002-6089-7716
References
- Yang, M., Luo M, Deng D, et al. Clinical characteristics and surgical outcomes in patients with intermittent exotropia: a large sample study in South China. Medicine (Baltimore). February 2016;95(5):e2590. doi:10.1097/MD.0000000000002590.
- Hardesty HH, Boynton JR, Keenan JP. Treatment of intermittent exotropia. Arch Opthalmol. 1978;96:268–274. doi:10.1001/archopht.1978.03910050136006.
- Oh JY, Hwang JM. Survival analysis of 365 patients with exotropia after surgery. Eye. 2006;20:1268–1272. doi:10.1038/sj.eye.6702091.
- Scott AB MD, *, Miller JM PhD, Shieh KR BS. Treating strabismus by injecting the agonist muscle with bupivacaine and the antagonist with botulinum toxin. Trans Am Ophthalmol Soc. December 2009;107:104–109.
- Miller JM PhD, Scott AB MD, Danh KK, Strasser D, Sane M. Bupivacaine injection remodels extraocular muscles and corrects comitant strabismus. Ophthalmology. December 2013;120(12):2733–2740. doi:10.1016/j.ophtha.2013.06.003.
- Josephson ME, Mathias SA. Bupivacaine treatment of intermittent exotropia of the convergence insufficiency type. J AAPOS. 2011;15:e4. ( Abstract of AAPOS meeting presentation). doi:10.1016/j.jaapos.2011.01.016.
- Martinez-Thompson JM, Diehl NN, Holmes JM, Mohney BG. Incidence, types, and lifetime risk of adult-onset strabismus. Ophthalmology. April 2014;121(4):877–882. doi:10.1016/j.ophtha.2013.10.030.